Prostate Cancer

Prostate cancer is the most common cancer to affect Canadian men. One in seven men will be diagnosed with the disease in their lifetime.

Prostate cancer is a disease where some prostate cells have lost normal control of growth and division. They no longer function as healthy cells.

A cancerous prostate cell has the following features:
•    Uncontrolled growth
•    Abnormal structure
•    The ability to move to other parts of the body (invasiveness).

It is important to note that not all clusters of cells growing in a mass are cancerous, and that a prostate with an irregular shape is not necessarily cancerous either. It is advisable to ask your doctor what it may be.

Prostate cancer can be slow-growing and some men who develop prostate cancer may live many years without ever having the cancer detected. It is important to get screened regularly so that if you do develop prostate cancer, the appropriate action can be taken. A significant proportion of prostate cancers, if untreated, may have serious consequences.

 
 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive